Drug comparisons
Dapagliflozin vs Alogliptin
Compare Dapagliflozin vs Alogliptin for type 2 diabetes treatment. Explore SGLT2 vs DPP-4 differences, heart/kidney benefits, side effects, and suitability.
No comparison dimensions are available for this page.
Clinical context
This comparison is triggered when selecting between an SGLT2 inhibitor and a DPP-4 inhibitor for type 2 diabetes patients with or without cardiovascular or renal comorbidities.
Bottom line
Dapagliflozin typically provides added cardiovascular and renal benefits over alogliptin, though neither is universally superior.
All medication comparisons